faculty scholarship BLOG 

West Virginia College of Law professor S. Sean Tu recently published new scholarship in the New England Journal of Medicine. The article is titled Leveraging Old Hepatitis C Therapies. Professor Tu co-authored the article with Shyamasundaran Kottilil, M.B., B.S., Ph.D. (University of Maryland School of Medicine), and T. Joseph Mattingly II, Pharm.D., M.B.A., Ph.D (University of Utah College of Pharmacy). It was published online by the journal on December 28, 2024 and subsequently in print in volume 392 on January 2, 2025.

Find more of Professor Tu's scholarship on SSRN.

West Virginia College of Law professor S. Sean Tu recently published new scholarship in the Journal of Law and the Biosciences. The article is titled "Accelerating biosimilar market access: the case for allowing earlier standing". Professor Tu's co-authors are: Rachel Goode and Matthew Turner of Fresenius Kabi Biopharma, and Victor Van de Wiele, Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women’s Hospital. The article was published online by the journal on January 3, 2025 and subsequently in print in volume 12, issue 1 of the journal.

From the abstract:

West Virginia College of Law professor S. Sean Tu recently published new scholarship in the Journal of Law, Medicine & Ethics. The article is titled "Use of Public Research and Manufacturing Enterprises to Lower Prescription Drug Prices and Increase Innovation ". Professor Tu's co-authors are: Alex Moss, Public Interest Patent Law Institute and Dana Brown, The Democracy Collaborative. The article was published online by the journal on December 16, 2024 and subsequently in print in volume 52, issue 3 of the journal.

From the abstract:

West Virginia College of Law professor S. Sean Tu published new scholarship in the New England Journal of Medicine. The article is titled "Clearing Dense Drug-Patent Thickets ". Professor Tu's co-authors are: Bernard Chao, University of Denver Sturm College of Law; Ryan Whalen, University of Hong Kong; and Aaron S. Kesselheim, Brigham and Women’s Hospital. The article was published online by the journal on November 27, 2024 and subsequently in print on December 12, 2024.

From the abstract:

West Virginia University College of Law professor  S. Sean Tu recently published a new Special Communication in JAMA. The article is titled  "Differential Legal Protections for Biologics vs Small-Molecule Drugs in the US," and explores the premise that biologics require more time and resources to develop and have weaker patent protection, necessitating additional protections for manufacturers to recoup their development costs and generate adequate returns on investment.

Professor Tu co-authored with work with Olivier J. Wouters, London School of Economics and Political Science, Matthew Vogel, John F. Kennedy School of Government at Harvard University, William B. Feldman, Brigham and Women’s Hospital and Harvard Medical School; Reed F. Beall, Cumming School of Medicine at University of Calgary; and Aaron S. Kesselheim, also of Brigham and Women’s Hospital and Harvard Medical School. It was published online by the journal on November 24, 2024.